Cooler Screens raises $80M to bring interactive screens into cooler aisles
Cooler Screens, the IoT-powered ad tech startup rolling out its product in 2,500 Walgreens stores, just raised over $80 million in Series C funding
Skyhawk Therapeutics Expands Leadership Team with Chief Medical Officer and Head of Chemistry, and adds to its Scientific Advisory Board
Activist Erin Brockovich Says It's Time to Start Treating 911 Operators as Frontline Workers
RapidDeploy Enters into Agreements with Google, OnStar, ADT, Priority Dispatch and Rave Mobile Safety to Transform U.S. Emergency Response Systems
First-In-Human Data Supporting the Safety of Glympse Bio's Biosensors are Presented at the AASLD 2020 Annual Meeting
Sidecar Health Expands Revolutionary "Cash Price" Health Insurance to Three Additional States
New Research Study Validates Performance and Accuracy of Truvian Sciences' Easy Check COVID-19 IgM/IgG™ Test
Truvian Sciences Announces Plans to Make Rapid Antibody Testing More Accessible with Easy Check COVID-19 IgM/IgG™ POC Antibody Test
Berkshire Hathaway Energy Subsidiaries Double Down on AI and Predictive Maintenance for Wind Fleets with Uptake Technologies
Skyhawk Therapeutics Expands Leadership Team with Chief Medical Officer and Head of Chemistry, and adds to its Scientific Advisory Board
With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests
Hacking Postgres: DJ Patil and Ray Lane Interview, GreatPoint Ventures -- YouTube
Pete Soderling's Zero Prime Podcast: Episode 13 with DJ Patil. Pete and DJ speak about all things data!
Examining the "Integration Layer" - Breaking down GreatPoint's investment in Onymos
Ep. 9 R K Anand, CEO & Co-Founder, Recogni
Join the BMW iVentures team as they speak with CEO and Co-Founder of Recogni, RK Anand, on the company’s advancement of visual-perception technology in autonomous vehicles.
Episode 2: Interview with our Co-founder and Chief Business Officer, Ashwini Choudhary
Q&A with Tailored Brands: How they Adapted Omnichannel Retail to the COVID-19 Era